Physician profile
Jason Brocker
NPI 1952564395
$33,461.85
in general payments reported to CMS, 2019-2025
8 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $22K · 2021: $3,134 · 2022: $998 · 2023: $3,847 · 2024: $3,135 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,770 · Food and Beverage: $342 · Travel and Lodging: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,770.00 |
| Food and Beverage | $342.39 |
| Travel and Lodging | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $32,306.89 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Integra Lifesciences Corporation | $381.60 | 2022 | |
| Davol INC. | $214.96 | 2022-2025 | Phasix Mesh |
| Boston Scientific Corporation | $167.47 | 2023-2024 | Spyglass Discover |
| Zimmer Biomet Holdings, INC. | $164.85 | 2022 | |
| Allergan, INC. | $118.23 | 2021 | |
| Teleflex LLC | $87.85 | 2022 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Brocker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.